EGFR-Directed Therapy in Lung Cancer

Discover the groundbreaking insights in "EGFR-Directed Therapy in Lung Cancer" by So Yeon Kim, published by Cambridge University Press in 2023. This insightful paperback, spanning 75 pages, delves into the structural biology and pathophysiology of EGFR-mutant non-small cell lung cancer (NSCLC). The book offers a comprehensive overview of past, current, and future treatment options tailored for various clinical settings. It also highlights recent advancements in the treatment of EGFR-exon 20 insertion mutations, as well as strategies for addressing uncommon mutations. Ideal for medical professionals and researchers, this Element is an essential resource for anyone looking to deepen their understanding of EGFR-directed therapies in lung cancer. Enhance your knowledge and stay ahead in the field with this essential read.